HAEMONETICS CORP (HAE) research
HAEMONETICS CORP- Sector
- Health Care
- Last price
- $108.52
- As of
HAEMONETICS CORP (HAE): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-18.
As of . Source: SEC EDGAR filings for HAE. Method and limitations.
Share the HAE intelligence card
See HAE live in the terminal
Track HAE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live HAE terminal, freeActive signals for HAE
- highCONSENSUS_BUY
5 tracked funds increased HAE this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased HAE this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +92% to HAE (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +5730% to HAE (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +922% to HAE (2026Q2)
FREE, NO ACCOUNT
Every signal on HAE, as it fires
You are seeing 5 of 37 signals recorded on HAE since 2026-05-17.
The five above landed across 2 days. The other 32 were recorded on 3 other days. 30 of the 37 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HAE (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 405024100 · 2026Q2 | $113.3M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 405024100 · 2026Q2 | $42.8M | 0.02% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 405024100 · 2026Q2 | $9.8M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 405024100 · 2026Q2 | $8.2M | 0.01% | , |
| Bridgewater Associates, LPCUSIP 405024100 · 2026Q2 | $4.5M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 405024100 · 2026Q2 | $2.7M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 405024100 · 2026Q2 | $794K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HAE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
HAE against its peers
HAE's operating margin of 11.7% ranks in the 60th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | HAE | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.3B USD | 1.5B USD | 37 | 25 |
| Gross margin | 59.0% | 59.9% | 48 | 19 |
| Operating margin | 11.7% | 6.0% | 60 | 23 |
| Net margin | 7.3% | 1.7% | 67 | 25 |
| Return on equity | 12.2% | 3.0% | 62 | 24 |
| P / E | 52.9x | 34.2x | 77 | 14 |
Peers (25): WAY, MMSI, DOCS, TFX, ITGR, LIVN, RDNT, NVST, HIMS, LNTH, CHE, OPCH, IRTC, CRVL, PACS, HNGE, WGS, TMDX, AVAH, ATRC, BKD, ACHC, MASI, PRVA, GKOS. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (HAE: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more HAE signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HAEand get the insider, 13F, options, and confluence read in one view.